BlackRock Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,977,716
-27.0%
894,894
-16.1%
0.00%
Q1 2023$2,710,207
+22.9%
1,067,011
-9.5%
0.00%
Q4 2022$2,204,339
-28.7%
1,178,791
-2.0%
0.00%
Q3 2022$3,092,000
+84.3%
1,203,446
+38.5%
0.00%
Q2 2022$1,678,000
-80.8%
869,224
-70.4%
0.00%
Q1 2022$8,734,000
-34.7%
2,940,513
-1.2%
0.00%
Q4 2021$13,370,000
-5.7%
2,977,680
+2.1%
0.00%
Q3 2021$14,177,000
-28.3%
2,917,140
+0.7%
0.00%
-100.0%
Q2 2021$19,759,000
-19.5%
2,897,320
-16.7%
0.00%0.0%
Q1 2021$24,557,000
+13.8%
3,478,440
+0.9%
0.00%0.0%
Q4 2020$21,580,000
+31.6%
3,447,329
+13.7%
0.00%0.0%
Q3 2020$16,398,000
+13.7%
3,030,848
+9.7%
0.00%0.0%
Q2 2020$14,416,000
+90.0%
2,761,736
+14.6%
0.00%
Q1 2020$7,588,000
-19.0%
2,408,849
+3.7%
0.00%
Q4 2019$9,366,000
-18.1%
2,323,912
-12.2%
0.00%
Q3 2019$11,436,000
+12.2%
2,646,900
+3.6%
0.00%
Q2 2019$10,193,000
-27.1%
2,554,792
-2.0%
0.00%
-100.0%
Q1 2019$13,977,000
+1.8%
2,607,486
-2.6%
0.00%0.0%
Q4 2018$13,729,000
-47.1%
2,676,432
-0.0%
0.00%0.0%
Q3 2018$25,967,000
-1.5%
2,677,154
+3.6%
0.00%0.0%
Q2 2018$26,350,000
-0.1%
2,583,390
+27.3%
0.00%0.0%
Q1 2018$26,374,000
-22.6%
2,028,845
+6.6%
0.00%
-50.0%
Q4 2017$34,075,000
-29.6%
1,903,651
-1.4%
0.00%0.0%
Q3 2017$48,436,000
+6.2%
1,929,713
+2.0%
0.00%0.0%
Q2 2017$45,608,000
+57.5%
1,892,447
+25.8%
0.00%0.0%
Q1 2017$28,950,000
+93287.1%
1,503,842
+73008.5%
0.00%
Q4 2016$31,000
+72.2%
2,057
+49.7%
0.00%
Q3 2016$18,000
-5.3%
1,3740.0%0.00%
Q2 2016$19,000
+72.7%
1,374
+89.8%
0.00%
Q1 2016$11,000
+83.3%
724
+149.7%
0.00%
Q4 2015$6,0000.0%2900.0%0.00%
Q3 2015$6,000
-14.3%
2900.0%0.00%
Q2 2015$7,0002900.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders